Skip to content
Screener

Haemonetics HAE Apheresis — Net revenues

Similar metrics at other companies

ROP
ROPProduct Revenue — Net revenues
$462.7M+7.7%
Travel + Leisure logo
TNLDeferred subscription revenue — Net revenues
$42M-2.3%
ROP
ROPTotal Software Revenue — Net revenues
$1.63B+12.4%
Travel + Leisure logo
TNLDeferred exchange-related revenue — Net revenues
$9M0.0%
Gen Digital Inc. logo
GENSubscription and service revenue — Net revenues
$1.33B+6.2%
Beyond Meat logo
BYNDInternational net revenues — Net revenues
$31.19M+0.6%

Other financials

Income statement

See full
Revenue$339.4M+5.6%
Gross profit$202.8M+5.5%
Operating income$57.5M+6.7%
Net income$33.0M-3.0%
EPS (diluted)$0.72+2.9%

Balance sheet

See full
Cash & equivalents$223.4M-23.7%
Total debt$1.2B-4.1%
Total equity$837.1M-5.1%
Total assets$2.4B-3.9%

Cash flow

See full
Operating cash flow$52.3M+201%
CapEx$7.9M+111%
Free cash flow$44.4M+226%

Valuation

See full
Market cap$3.87B+6.3%
Enterprise value$4.82B+5.4%
P/E25.7×-10.5×
P/S2.9×+0.2×

Profitability

See full
Gross margin59%+2.1pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin21.5%+7.5pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.4×0.0×
Current ratio3.1×+1.4×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Haemonetics’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:09 AM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0000313143-26-000120
Line itemThree Months Ended / June 27, 2026June 28, 2025
Apheresis
Plasma$155,524$145,074
Other35,79436,662
Apheresis net revenues$191,318$181,736
MedSurg
Interventional Technologies$59,942$58,483
Blood Management Technologies88,12081,175
MedSurg net revenues$148,062$139,658

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Haemonetics's apheresis — net revenues?
Haemonetics (HAE) reported apheresis — net revenues of $191.32M in Q2 2026.
What does apheresis — net revenues mean?
This metric represents the total revenue generated from the sale of products and services within the apheresis business segment after accounting for returns, allowances, and discounts. It serves as a primary indicator of the segment's market demand and its contribution to the company's overall top-line growth. Monitoring this figure helps investors assess the commercial success of blood component collection technologies and the segment's competitive positioning.

Ask your AI about Haemonetics's apheresis — net revenues.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude